S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine
Authors
Keywords
Pancreatic ductal adenocarcinoma, S100A16, Epithelial-mesenchymal transition, TWIST1, Gemcitabine
Journal
BIOCHEMICAL PHARMACOLOGY
Volume -, Issue -, Pages 114396
Publisher
Elsevier BV
Online
2020-12-25
DOI
10.1016/j.bcp.2020.114396
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
- (2020) Jia-qiao Fan et al. Molecular Cancer
- Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis
- (2020) Hui Sun et al. Cell Death & Disease
- Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation
- (2020) Francesca Ricciardiello et al. ONCOGENE
- Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846
- (2020) Teppei Sugano et al. BRITISH JOURNAL OF CANCER
- S100A16, a novel lipogenesis promoting factor in livers of mice and hepatocytes in vitro
- (2019) Jingbao Kan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Biochemical pathways mediated by KLK 6 protease in breast cancer
- (2019) Georgios Pampalakis et al. Molecular Oncology
- Predictive value of intratumour inflammatory cytokine mRNA levels of hepatocellular carcinoma patients and activation of two distinct pathways govern IL-8 induced epithelial-mesenchymal transition in human hepatic cancer cell lines
- (2019) Siqi Peng et al. CYTOKINE
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16
- (2019) Huifang Lv et al. ONCOLOGY RESEARCH
- Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma
- (2018) Makoto Kobayashi et al. HUMAN PATHOLOGY
- Identification of Sox6 as a regulator of pancreatic cancer development
- (2018) Weiliang Jiang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells
- (2018) Chumei Huang et al. Theranostics
- Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-α and MMP-9
- (2018) Seungeun Lee et al. CANCER LETTERS
- Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
- (2018) Zachary A. Yochum et al. ONCOGENE
- Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
- (2018) Andrew McGuigan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- FAK inhibitors in Cancer, a patent review
- (2017) Peng-Cheng Lv et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression
- (2017) Yu Zhu et al. IMMUNITY
- S100A16 is a prognostic marker for colorectal cancer
- (2017) Xu Sun et al. JOURNAL OF SURGICAL ONCOLOGY
- The EMT spectrum and therapeutic opportunities
- (2017) Dominic C. Voon et al. Molecular Oncology
- S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma
- (2017) Ken Katono et al. OncoTargets and Therapy
- Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
- (2017) Yoshiaki Sunami et al. Cancers
- Hypoxia induces TWIST-activated epithelial–mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice
- (2016) Shi Chen et al. CANCER LETTERS
- S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma
- (2015) Dipak Sapkota et al. BMC CANCER
- Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
- (2015) Spring Holter et al. JOURNAL OF CLINICAL ONCOLOGY
- The epithelial to mesenchymal transition in pancreatic cancer: A systematic review
- (2015) Mircea Beuran et al. PANCREATOLOGY
- Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
- (2015) R. M. Perera et al. Cancer Discovery
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
- (2008) Paola Allavena et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now